Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sharlin Health and Neurology reports measurable improvements in cognitive decline through their Brain Tune Up! protocol, has contributed site patients to the largest published case series on cognitive decline reversal, and has participated in pivotal research leading to FDA-approved treatments for Alzheimer's (donanemab) and MS (ofatumumab)
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sharlin Health and Neurology.